293 related articles for article (PubMed ID: 12583008)
1. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
3. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
6. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
[TBL] [Abstract][Full Text] [Related]
7. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
Steinijans VW; Trautmann H; Sauter R; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of an extended-release theophylline product in cats.
Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
Steinijans VW; Sauter R; Böhm A; Staudinger H
Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
11. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
14. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
Cova D; Cuglituri G; Rossini L; Bonfardeci G
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger H; Steinijans VW
Am Rev Respir Dis; 1990 Jul; 142(1):84-90. PubMed ID: 2195936
[TBL] [Abstract][Full Text] [Related]
20. Alteration of pharmacokinetics after halving a slow-release theophylline tablet.
Primrose WR; Clee MD; Moody JP; Hockings N
Pharmatherapeutica; 1983; 3(6):429-32. PubMed ID: 6622502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
